Akero Therapeutics Inc (AKRO)

05:17 AM

Will Akero Therapeutics Inc. Benefit From Broader Market BounceWeekly Stock Watch With Growth Focus Expanded - metal.it

05:17 AM

05:08 AM

33,611 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Bought by Picton Mahoney Asset Management - MarketBeat

05:08 AM

04:31 AM

Victory Capital Management Inc. Buys 27,881 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

04:31 AM

04:29 AM

Skandinaviska Enskilda Banken AB publ Purchases Shares of 7,676 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

04:29 AM

Jul 29, 2025

How Akero Therapeutics Inc. stock performs during market volatilityWeekly Watchlist of High Movers Released - beatles.ru

Jul 29, 2025

Jul 29, 2025

Teachers Retirement System of The State of Kentucky Trims Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 29, 2025

Jul 29, 2025

Akero Therapeutics Inc. Forms Bullish Flag — Upside AheadAI Screening for Swing Trade Picks Finds Momentum - metal.it

Jul 29, 2025

Jul 28, 2025

What makes Akero Therapeutics Inc. stock price move sharplyMarket Forecast Picks That Work - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

How strong is Akero Therapeutics Inc. company’s balance sheetFree Daily Trading Room Entry - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

What are the technical indicators suggesting about Akero Therapeutics Inc.Build a diversified portfolio for maximum returns - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

Is it the right time to buy Akero Therapeutics Inc. stockSuperior capital gains - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Is Akero Therapeutics Inc. a growth stock or a value stockUnlock expert trading strategies for growth - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Jennison Associates LLC Invests $533,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 27, 2025

Jul 26, 2025

100,500 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Acquired by Readystate Asset Management LP - MarketBeat

Jul 26, 2025

Jul 26, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Holdings Lowered by Kennondale Capital Management LLC - MarketBeat

Jul 26, 2025

Jul 25, 2025

AstraZeneca’s Anselamimab Misses Primary Endpoint in Amyloidosis Trials, Shows Promise in Subgroup - MSN

Jul 25, 2025

Jul 25, 2025

What analysts say about Akero Therapeutics Inc. stockTremendous growth potential - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Is Akero Therapeutics Inc. a good long term investmentFast-track wealth growth - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What drives Akero Therapeutics Inc. stock priceHigh-margin investment plays - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Bank of New York Mellon Corp Purchases 12,235 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 25, 2025

Jul 24, 2025

Is Akero Therapeutics Inc. stock a growth or value playFree Trend-Following Techniques - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

How to Take Advantage of moves in (AKRO) - news.stocktradersdaily.com

Jul 24, 2025

Jul 24, 2025

Edgestream Partners L.P. Acquires Shares of 6,947 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 24, 2025

Jul 23, 2025

Akero Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - Autocar Professional

Jul 23, 2025

Jul 23, 2025

5,565 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Bought by Xponance Inc. - MarketBeat

Jul 23, 2025

Jul 22, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $529,500.00 in Stock - MarketBeat

Jul 22, 2025